Literature DB >> 19627450

Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.

Irit Rappley1, David S Myers, Stephen B Milne, Pavlina T Ivanova, Matthew J Lavoie, H Alex Brown, Dennis J Selkoe.   

Abstract

Advances in lipidomics technology have facilitated the precise detection, identification and profiling of lipid species within tissues. Mass spectrometry allows for identification of lipids as a function of the total number of carbons and double bonds in their acyl chains. Such detailed descriptions of lipid composition can provide a basis for further investigation of cell signaling and metabolic pathways, both physiological and pathological. Here, we applied phospholipid profiling to mouse models relevant to Parkinson's disease, using mice that were transgenic for human alpha-synuclein (alphaSyn) or deleted of endogenous alphaSyn. Proposed functions of alphaSyn include phospholipid binding, regulation of membrane composition, and regulation of vesicular pools. We investigated whether alphaSyn gene dosage interacts with differences in phospholipid composition across brain regions or with age-related changes in brain phospholipid composition. The most dramatic phospholipid changes were observed in alphaSyn wild-type animals as a function of age and gender. alphaSyn genotype-specific changes were also observed in aged, but not young, mice. Our results provide a detailed and systematic characterization of brain phospholipid composition in mice and identify age-related changes relevant both to Parkinson's disease and to normal aging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627450      PMCID: PMC2752313          DOI: 10.1111/j.1471-4159.2009.06290.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice.

Authors:  Gwendolyn Barceló-Coblijn; Mikhail Y Golovko; Isabella Weinhofer; Johannes Berger; Eric J Murphy
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

2.  Sublimation as a method of matrix application for mass spectrometric imaging.

Authors:  Joseph A Hankin; Robert M Barkley; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-30       Impact factor: 3.109

3.  Prime time for alpha-synuclein.

Authors:  Aaron D Gitler; James Shorter
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

4.  Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.

Authors:  Carol A Rouzer; Pavlina T Ivanova; Mark O Byrne; Stephen B Milne; Lawrence J Marnett; H Alex Brown
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

5.  Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling.

Authors:  Hua Cheng; David J Mancuso; Xuntian Jiang; Shaoping Guan; Jingyue Yang; Kui Yang; Gang Sun; Richard W Gross; Xianlin Han
Journal:  Biochemistry       Date:  2008-05-03       Impact factor: 3.162

6.  Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry.

Authors:  Pavlina T Ivanova; Stephen B Milne; Mark O Byrne; Yun Xiang; H Alex Brown
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

7.  Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells.

Authors:  Karen Assayag; Evgenia Yakunin; Virginie Loeb; Dennis J Selkoe; Ronit Sharon
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

Review 8.  Physiological and pathological properties of alpha-synuclein.

Authors:  G K Tofaris; M G Spillantini
Journal:  Cell Mol Life Sci       Date:  2007-09       Impact factor: 9.261

9.  Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.

Authors:  Laxman Yetukuri; Mikko Katajamaa; Gema Medina-Gomez; Tuulikki Seppänen-Laakso; Antonio Vidal-Puig; Matej Oresic
Journal:  BMC Syst Biol       Date:  2007-02-15

Review 10.  The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

Authors:  Irene Litvan; Marie-Francoise Chesselet; Thomas Gasser; Donato A Di Monte; Davis Parker; Theo Hagg; John Hardy; Peter Jenner; Richard H Myers; Donald Price; Mark Hallett; William J Langston; Anthony E Lang; Glenda Halliday; Walter Rocca; Charles Duyckaerts; Dennis W Dickson; Yoav Ben-Shlomo; Christopher G Goetz; Eldad Melamed
Journal:  J Neuropathol Exp Neurol       Date:  2007-05       Impact factor: 3.685

View more
  36 in total

1.  Effects of curvature and composition on α-synuclein binding to lipid vesicles.

Authors:  Elizabeth R Middleton; Elizabeth Rhoades
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH.

Authors:  Stephan Laggai; Yvette Simon; Theo Ranssweiler; Alexandra K Kiemer; Sonja M Kessler
Journal:  World J Hepatol       Date:  2013-10-27

3.  Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 4.  Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses.

Authors:  Xianlin Han; Kui Yang; Richard W Gross
Journal:  Mass Spectrom Rev       Date:  2011-07-13       Impact factor: 10.946

Review 5.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

Review 6.  Lipidomics: when apocrypha becomes canonical.

Authors:  H Alex Brown
Journal:  Curr Opin Chem Biol       Date:  2012-02-28       Impact factor: 8.822

7.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

8.  Α-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease.

Authors:  Eugenia Yakunin; Virginie Loeb; Haya Kisos; Yoav Biala; Shlomo Yehuda; Yoel Yaari; Dennis J Selkoe; Ronit Sharon
Journal:  Brain Pathol       Date:  2011-10-31       Impact factor: 6.508

9.  α-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway.

Authors:  Ruth E J Musgrove; Anna E King; Tracey C Dickson
Journal:  Neurotox Res       Date:  2012-08-31       Impact factor: 3.911

Review 10.  Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation.

Authors:  David S Myers; Pavlina T Ivanova; Stephen B Milne; H Alex Brown
Journal:  Biochim Biophys Acta       Date:  2011-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.